Main Title |
Pargyline and gamma-Butyrolactone Enhance Tyrosine Hydroxylase Immunostaining of Nigrostriatal Axons. |
Author |
Haykal-Coates, N. ;
O'Callaghan, J. P. ;
Reinhard, J. F. ;
Jensen, K. F. ;
|
CORP Author |
Health Effects Research Lab., Research Triangle Park, NC. Neurotoxicology Div. ;ManTech Environmental Technology, Inc., Research Triangle Park, NC. ;Wellcome Research Labs., Research Triangle Park, NC. |
Publisher |
c1991 |
Year Published |
1991 |
Report Number |
EPA/600/J-91/211; |
Stock Number |
PB91-243022 |
Additional Subjects |
Pargyline ;
4-Butyrolactone ;
Tyrosine hydroxylase ;
Axons ;
Substantia nigra ;
Immunohistochemistry ;
Pharmacology ;
Biosynthesis ;
Neuroregulators ;
Western blotting ;
Reprints ;
|
Holdings |
Library |
Call Number |
Additional Info |
Location |
Last Modified |
Checkout Status |
NTIS |
PB91-243022 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
Collation |
7p |
Abstract |
Administration of pargyline or gamma-butyrolactone enhanced immunostaining of tyrosine hydroxylase immunoreactive axons in the striatum. The qualitative characteristics of the enhancement were compound dependent and the enhancement was not associated with an increase in the amount of tyrosine hydroxylase within the striatum. These results demonstrate the pharmacological enhancement of immunostaining for neurotransmitter synthetic enzymes in the absence of increased synthesis. (Copyright (c) 1991 Elsevier Science Publishers B.V.) |